Last Updated: 16 Sep 2024
Executive Summary
HIVE Blockchain Technologies Ltd (HIVE) is a publicly traded company listed on the NASDAQ exchange. The company operates in the technology sector, specifically in the computer processing and data preparation industry. HIVE designs and develops cloud networks and enterprise Wi-Fi solutions. The company has a market capitalization of $365.56 million and its latest stock price is $3.08.
Company Overview
HIVE is headquartered in Milpitas, California and operates in the Americas, Europe, the Middle East and Africa, and Asia Pacific. The company's products and services include cloud networks, enterprise Wi-Fi solutions, and network management tools. HIVE's customers include businesses, government agencies, and educational institutions.
Fundamental Analysis
HIVE's financial performance has been mixed in recent years. The company's revenue has grown steadily, but its profitability has been volatile. In the latest quarter, HIVE reported a loss per share of $0.35. The company's gross profit margin was 13.3% and its operating margin was -23.4%. HIVE's return on assets was -8.78% and its return on equity was -15.3%.
HIVE's balance sheet is relatively strong. The company has $163.93 million in cash and equivalents and $123.14 million in total debt. HIVE's book value per share is $2.329.
Technical Analysis
HIVE's stock price has been in a downtrend in recent months. The stock is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is 30.08, which indicates that the stock is oversold.
Short Term Outlook
HIVE's stock price is likely to remain under pressure in the short term. The company's financial performance has been weak and the stock is trading below its moving averages. The RSI is also indicating that the stock is oversold.
Long Term Outlook
HIVE's long-term outlook is uncertain. The company's financial performance has been mixed and the stock price has been volatile. However, the company's products and services are in demand and the company has a strong balance sheet.
Analyst Recommendations
Four analysts have a "buy" rating on HIVE, while no analysts have a "sell" rating. The average analyst target price is $5.91.
